These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30516526)

  • 1. Is there a gender gap in secondary prevention of coronary artery disease in Turkey?
    Koçyiğit D; Tokgözoğlu L; Kayıkçıoğlu M; Altay S; Aydoğdu S; Barçın C; Bostan C; Çakmak HA; Çatakoğlu AB; Emet S; Ergene O; Kalkan AK; Kaya B; Kaya C; Kaymaz C; Koylan N; Kültürsay H; Oğuz A; Özpelit E; Ünlü S
    Turk Kardiyol Dern Ars; 2018 Dec; 46(8):683-691. PubMed ID: 30516526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of coronary artery disease in Kyrgyzstan: a comparison with Turkey and europe according to European Action on Primary and secondary prevention by intervention to reduce events III results.
    Kutlu R; Muratalievic TM; Memetoglu ME
    Turk Kardiyol Dern Ars; 2014 Sep; 42(6):545-52. PubMed ID: 25362945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [EUROASPIRE-IV: European Society of Cardiology study of lifestyle, risk factors, and treatment approaches in patients with coronary artery disease: Data from Turkey].
    Tokgözoğlu L; Kayıkçıoğlu M; Altay S; Aydoğdu S; Barçın C; Bostan C; Çakmak HA; Çatakoğlu AB; Emet S; Ergene O; Kalkan AK; Kaya B; Tulunay Kaya C; Kaymaz C; Koylan N; Kültürsay H; Oğuz A; Özpelit E; Ünlü S
    Turk Kardiyol Dern Ars; 2017 Mar; 45(2):134-144. PubMed ID: 28424435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey.
    Kotseva K; Wood D; De Bacquer D;
    Eur J Prev Cardiol; 2018 Aug; 25(12):1242-1251. PubMed ID: 29873511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated risk profile of women in secondary prevention of coronary artery disease: a 6-year survey of 117,913 patients.
    Reibis RK; Bestehorn K; Pittrow D; Jannowitz C; Wegscheider K; Völler H
    J Womens Health (Larchmt); 2009 Aug; 18(8):1123-31. PubMed ID: 19630543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
    Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
    Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology.
    De Smedt D; De Bacquer D; De Sutter J; Dallongeville J; Gevaert S; De Backer G; Bruthans J; Kotseva K; Reiner Ž; Tokgözoğlu L; Clays E
    Int J Cardiol; 2016 Apr; 209():284-90. PubMed ID: 26913370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Data on secondary prevention of coronary artery disease in Hungary and some changes in the last ten years (EUROASPIRE 1995-2005)].
    Jánosi A; Ostör E; Borbás S; Kazinczy R; Káli A; Vámos I; Bradák A; Podmaniczky M
    Orv Hetil; 2010 Oct; 151(43):1776-82. PubMed ID: 20940117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of risk factors and prophylactic drug usage in Turkish patients with angiographically established coronary artery disease.
    Sonmez K; Akcay A; Akcakoyun M; Demir D; Elonu OH; Pala S; Duran NE; Gencbay M; Degertekin M; Turan F
    J Cardiovasc Risk; 2002 Aug; 9(4):199-205. PubMed ID: 12394328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention in patients after hospitalisation due to coronary artery disease: what has changed since 2006?
    Jankowski P; Czarnecka D; Lysek R; Skrzek A; Smaś-Suska M; Mazurek A; Brzozowska-Kiszka M; Wolfshaut-Wolak R; Surowiec S; Bogacki P; Bryniarska-Mirek E; Bryniarski L; Grodecki J; Nessler J; Olszowska M; Podolec P; Kawecka-Jaszcz K; Pająk A
    Kardiol Pol; 2014; 72(4):355-62. PubMed ID: 24408064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
    Kumbhani DJ; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Deedwania P; Grau-Sepulveda M; Schwamm LH; Bhatt DL;
    Am J Med; 2015 Apr; 128(4):426.e1-9. PubMed ID: 25433302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event.
    Dallongevillle J; De Bacquer D; Heidrich J; De Backer G; Prugger C; Kotseva K; Montaye M; Amouyel P;
    Heart; 2010 Nov; 96(21):1744-9. PubMed ID: 20956490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of gender on treatment and clinical outcomes in acute ST elevation myocardial infarction patients in Thailand.
    Srichaiveth B; Ruengsakulrach P; Visudharom K; Sanguanwong S; Tangsubutr W; Insamian P
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():65-73. PubMed ID: 18431888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Educational level and risk profile and risk control in patients with coronary heart disease.
    Bruthans J; Mayer O; De Bacquer D; De Smedt D; Reiner Z; Kotseva K; Cífková R;
    Eur J Prev Cardiol; 2016 May; 23(8):881-90. PubMed ID: 26283652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trends of gender-based differences in lipid goal attainments during secondary prevention of coronary artery disease: results of a 5-year survey.
    Singh M; Chin SH; Crothers D; Giles P; Al-Allaf K; Khan JM
    Am J Ther; 2013; 20(6):613-7. PubMed ID: 23344096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
    Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
    [No Abstract]   [Full Text] [Related]  

  • 19. Administration and effects of secondary prevention measures in coronary heart disease patients from Serbia according to gender and cardiometabolic risk.
    Tasic I; Lazarevic G; Kostic S; Djordjevic D; Simonovic D; Rihter M; Vulic D; Stefanovic V
    Acta Cardiol; 2010 Aug; 65(4):407-14. PubMed ID: 20821933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey.
    Griffo R; Ambrosetti M; Tramarin R; Fattirolli F; Temporelli PL; Vestri AR; De Feo S; Tavazzi L;
    Int J Cardiol; 2013 Aug; 167(4):1390-5. PubMed ID: 22575623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.